TrialEuropean urology2011

TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate.

Daniel C Danila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.